<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03642821</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-201702-OPTIMA</org_study_id>
    <nct_id>NCT03642821</nct_id>
  </id_info>
  <brief_title>Intracranial Aneurysms Treatment With the OPTIMA Coil System</brief_title>
  <acronym>INSTANT</acronym>
  <official_title>Intracranial Aneurysms Treatment With the OPTIMA Coil System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balt Extrusion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balt Extrusion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      International, non-randomized, European , multicenter, observational study to collect data
      for the treatment of intracranial aneurysms with OPTIMA coils system to further document its
      safety and efficacy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Morbi-mortality at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of adverse events including thromboembolic events, the bleeding/rebleeding episodes, the rate of retreated aneurysm and the rate of mortality occurring during the procedure and up to 30 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical outcomes (mRS) at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Classification of the patient clinical and neurological outcomes based on modified Rankin Scale from 0 (no symptoms a all) to 6 (dead). Global outcomes of mRS 0-2 are considered good and those of mRS 3-6 (including mRS 6 - deceased) are considered to be poor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbi-mortality at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Rate of adverse events including thromboembolic events, the bleeding/rebleeding episodes, the rate of retreated aneurysm and the rate of mortality occurring within 12 months after the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcomes (mRS) at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Classification of the patient clinical and neurological outcomes based on modified Rankin Scale from 0 (no symptoms a all) to 6 (dead). Global outcomes of mRS 0-2 are considered good and those of mRS 3-6 (including mRS 6 - deceased) are considered to be poor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm occlusion rate</measure>
    <time_frame>Up to 24h and 12 months</time_frame>
    <description>Post-procedure and 12-month follow-up efficacy based on the assessment of the aneurysm occlusion rate according to the 3-grade Montreal scale (complete occlusion/neck remnant/aneurysm remnant).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intracranial aneurysm coiling</intervention_name>
    <description>endovascular treatment of intracranial aneurysm by coiling procedure using OPTIMA coils system</description>
    <other_name>OPTIMA coils</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. giant aneurysms (&gt;25 mm)

          2. recanalized aneurysms initially treated with stent or flow diverter (Only aneurysms
             initially treated with coils are eligible)

          3. aneurysm treated with parent artery occlusion

          4. dissecting or fusiform aneurysms

          5. aneurysms associated with an arteriovenous malformation

          6. aneurysm intended to be treated with flow diverter or flow disrupter during the
             procedure

          7. aneurysm intended to be treated in a staged procedure

          8. intracranial tumor (except meningioma)

          9. Any condition or any situation that would prohibit the patient from coming to the
             investigational center for the follow-up, as requested according to sites current
             practice.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient with small or large intracranial aneurysm, ruptured or unruptured, intended to
             be selectively treated with the OPTIMA coil system. Patients with recanalized
             aneurysms previously treated with coils exclusively are also eligible. Balloon and
             stent assisted coiling are allowed at index procedure.

          2. In case of multiple aneurysms, patient can be included when only 1 aneurysm is treated
             during the procedure and none of the other aneurysms are treated up to 30 days
             post-procedure

          3. Patient older than 18 years

          4. Patient who has been informed of the study and has signed an informed consent form
             where applicable according to local regulations.

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Saliha HADDAG</last_name>
    <phone>+33 1 39 34 90 81</phone>
    <email>saliha.haddag@balt.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Berge</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Brest - Hôpital La Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Gentric</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hôpital Neurologique</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Eker</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Côte de Nâcre</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Barbier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Clairval</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Levrier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Gui de Chaulliac</name>
      <address>
        <city>Montpellier</city>
        <zip>Costalat</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Costalat</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Maison Blanche</name>
      <address>
        <city>Reims</city>
        <zip>51000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Pierot, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Charles-Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Papagiannaki</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Strasbourg Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pr Beaujeux</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentralklinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedallera</name>
      <address>
        <city>Catania</city>
        <zip>95126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Antonio Cardarelli Hospital</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Muto</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ULSS8 Berica Ospedale San Bortolo</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Iannucci</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Latvia, Faculty of Medicine</name>
      <address>
        <city>Riga</city>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Kupcs</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>09006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Lopez Martinez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital: Fundacion Jimenez Diaz</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Rodriguez Fernandez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital: Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>HUG Hôpital cantonal universitaire de geneva</name>
      <address>
        <city>Geneva</city>
        <zip>CH-1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr Machi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Latvia</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

